US Asthma Market and Competitive Landscape Highlights - 2016

  • ID: 3679716
  • Drug Pipelines
  • Region: United States
  • Fore Pharma
1 of 3
The latest research US Asthma Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Asthma pipeline products, Asthma epidemiology, Asthma market valuations and forecast, Asthma products sales and competitive landscape in the US.

The research is classified into nine sections – Asthma overview including etiology, pathophysiology, and diagnosis, Asthma treatment options, Asthma pipeline products, Asthma market analysis comprising of Asthma epidemiology, key products marketed for Asthma, market valuations and forecast, products sales and market shares.

Research Scope:
- Asthma Pipeline: Find out the products in clinical trials for the treatment of Asthma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Asthma Epidemiology: Find out the number of patients diagnosed (prevalence) with Asthma in the US
- Asthma Products: Identify key products marketed and prescribed for Asthma in the US, including trade name, molecule name, and company
- Asthma Product Sales: Find out the sales revenues of Asthma products, both branded and generics, in the US
- Asthma Market Valuations: Find out the market size for Asthma products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Asthma Products Market Share: Find out the market shares for key Asthma products in the US

Benefits of this Research:
The research helps executives to
- Support monitoring and reporting national Asthma market analysis and sales trends
- Track competitor drugs sales and market share in the US Asthma market
- Track competitive developments in Asthma market and present key issues and learnings
- Synthesize insights for Asthma market and products to drive business performance
- Answer key business questions about the Asthma market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Asthma products
- Supports decision making in R&D to long term marketing strategies

This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1) Disease Overview
a) Etiology
b) Pathophysiology
c) Diagnosis
2) Asthma Treatments
3) Asthma Pipeline
4) US Asthma Epidemiology
5) Marketed Drugs for Asthma in US
6) US Asthma Market Size
7) US Asthma Products Sales
8) US Asthma Market Competitive Landscape
9) US Asthma Market Forecast
10) Methodology
11) Contact us

1. Asthma Epidemiology, US, 2010 - 2020
2. Asthma Market Size ($), US, 2010 – 2015
3. Asthma Products Market Share (%), US, 2015
4. Asthma Market Forecast ($), US, 2015 – 2020

1. Asthma Phase 3 Clinical Trials, 2016
2. Asthma Phase 2 Clinical Trials, 2016
3. Asthma Phase 1 Clinical Trials, 2016
4. Asthma Epidemiology, US, 2010 - 2020
5. Marketed Drugs for Asthma, US, 2016
6. Asthma Market Size ($), US, 2010 – 2015
7. Asthma Product Sales ($), US, 2010 – 2015
8. Asthma Market Forecast ($), US, 2015 – 2020
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll